Fragmento

Next year will be the one hundredth anniversary of Carlos Chagas’ discovery of a disease that continues to endanger the lives of a significant number of people in the Americas, despite major successes in controlling its transmission and recent achievements in experimental specific chemotherapy against its etiological agent, Trypanosoma cruzi. Through its impact on worker productivity, premature disability, and death, Chagas disease accounts for 670,000 disability-adjusted life years (DALYs), making it the most noteworthy parasitic disease of the Americas. Furthermore, not only does primary infection continue to endanger the lives of countless people in the region, but the chronic manifestations of Chagas disease also affect the livelihood of many individuals previously infected. As the trend for global migration increases, the scope of Chagas disease threatens to expand exponentially, from rural to urban areas and endemic to non-endemic regions.

Palabras clave: .

2008-05-21   |   761 visitas   |   Evalua este artículo 0 valoraciones

Vol. 2 Núm.2. Abril 2008 Pags. 149-150. J Infect Developing Countries 2008; 2(2)